American Hospital Dubai and 10XREVIV have signed a non-binding memorandum of understanding to collaborate on precision, preventive and longevity healthcare across the UAE and the wider region. Under the agreement, 10XREVIV's MYiOX Health and MYiOX Pro platforms will be deployed within American Hospital Dubai's systems, giving clinicians new tools built around personalised data.
The platforms combine genetic data, biomarkers, nutrition information and artificial intelligence to help doctors design more tailored treatment and prevention plans. According to both organisations, the partnership will focus initially on precision nutrition, healthy ageing programmes, oncology support and additional training for clinicians working across the hospital's network.
Sherif Beshara, Group CEO of American Hospital Dubai, described the collaboration as an important step in strengthening Dubai's position as a regional hub for preventive healthcare. Brandon Dawson, Chairman and co-founder of 10XREVIV, said the partnership would give patients in the region access to advanced personalised health technology that has so far been limited to a small number of markets.
10XREVIV is a precision wellness and health technology company based in Masdar City, Abu Dhabi. Its agreement with one of Dubai's established hospital groups reflects a broader trend of UAE healthcare providers investing more heavily in personalised and predictive medicine rather than relying solely on traditional diagnostic approaches.
The announcement comes as Dubai's health sector continues to expand its network of facilities and specialists, part of a wider push to offer more preventive and specialised care to both residents and visitors. Officials in the sector have said that trend is expected to accelerate further as technologies similar to 10XREVIV's platforms become more widely adopted across hospitals in the emirate.